Dermapharm Holding SE (ETR:DMP)

Market Cap	2.42B +27.4%
Revenue (ttm)	1.18B -1.4%
Net Income	144.21M +39.2%
EPS	2.68 +39.3%
Shares Out	49.54M
PE Ratio	18.20
Forward PE	17.73
Dividend	0.88 (1.79%)
Ex-Dividend Date	Jun 29, 2026

Volume	124,098
Open	49.35
Previous Close	49.10
Day's Range	48.50 - 49.65
52-Week Range	31.70 - 51.90
Beta	0.86
Analysts	Buy
Price Target	47.88 (-1.78%)
Earnings Date	May 13, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,503
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DMP

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.